Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 42

Results For "UST"

5247 News Found

BC Jindal Foundation to raise healthcare CSR investment to Rs 16 crore in FY27
News | April 10, 2026

BC Jindal Foundation to raise healthcare CSR investment to Rs 16 crore in FY27

The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces


NITI Aayog releases reports to improve ease of doing R&D in India
Policy | April 10, 2026

NITI Aayog releases reports to improve ease of doing R&D in India

The reports will now be shared with relevant ministries and departments as a guidance framework


Ayush Ministry marks World Homoeopathy Day 2026, pushes research-led growth
Policy | April 10, 2026

Ayush Ministry marks World Homoeopathy Day 2026, pushes research-led growth

A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal


Chiba University study flags allergy risk in high-binding antibody drugs
Biopharma | April 09, 2026

Chiba University study flags allergy risk in high-binding antibody drugs

For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms


OPPI and NIPER Raebareli partner to boost pharma research and talent
News | April 09, 2026

OPPI and NIPER Raebareli partner to boost pharma research and talent

Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem


University of Leeds launches landmark HALO study on lifelong impact of childhood blood disorders
Hospitals | April 09, 2026

University of Leeds launches landmark HALO study on lifelong impact of childhood blood disorders

Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust


India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters
Drug Approval | April 09, 2026

India’s Dapagliflozin Moment: Why USFDA’s generic greenlight wave matters

In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga


Metropolis’ ARSH initiative touches 3.25 Lakh adolescents, deepening grassroots health impact
Hospitals | April 09, 2026

Metropolis’ ARSH initiative touches 3.25 Lakh adolescents, deepening grassroots health impact

CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change


GSK Pharma shareholders back Ronojit Biswas’ Board, CFO appointment via postal ballot
News | April 09, 2026

GSK Pharma shareholders back Ronojit Biswas’ Board, CFO appointment via postal ballot

Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker


Maharashtra MEMS 108 gets 1,756 new ambulances as Sumeet SSG partners Pinnacle
Healthcare | April 09, 2026

Maharashtra MEMS 108 gets 1,756 new ambulances as Sumeet SSG partners Pinnacle

36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108